BiQ: Happy Last Day of 2025!

Happy last day of 2025, everyone! It's been a very rewarding year for Biotech iQ, and I can't wait to see what 2026 brings. There are so many exciting companies doing amazing work and moving towards pivotal events in the coming year.

Whenever I stop to think about it, I am reminded of what a privilege it is to participate in this great scientific adventure of discovery. Starting with computer-aided molecular designs and early signals in small preclinical studies, the companies we invest in bring life-altering therapies to real people with real diseases, allowing them to live longer, healthier, and more productive lives. As investors, we get to participate in this journey.

Although I've been a biotech investor for almost two decades, I only launched Biotech iQ to the general public less than a year ago. I'm very grateful for the opportunity to interact with all of you, share ideas, commiserate over our defeats, and celebrate our successes together.

As we close out the year, here's a look back at the BiQ realized gains and losses table since the inception of this service.

As a final reminder, today is the last day to take advantage of the launch-year promotion (link below). Starting January 1st, the only promotion that will be offered is a 25% discount on your first year's subscription. Monthly subscriptions will still be available as well for those who wish to try Biotech iQ without committing to a full year.

As we head into the new year, I want to thank you all for your support of Biotech iQ, and wish you all continued success in your investing journey!

Not a BiQ Premium member, or have a friend who may be interested? Try BiQ Premium for $50 per month, or $250 (50% off) for the first year.

Biotech iQ is 100% subscriber supported. If you find this information helpful, please spread the word. You can also follow me on X @ Biotech iQ (_Biotech_iQ).

Biotech iQ is not an investment professional, and nothing on this page or this website should be considered investment advice. Please consult with a licensed investment professional as necessary. Past performance is not indicative of future results.